Skip to main content
. 2017 Oct 12;25:41–49. doi: 10.1016/j.ebiom.2017.10.011

Fig. 2.

Fig. 2

Progression-free survival (PFS) and overall survival (OS) curves of patients with ENKTL treated by MESA.

(A) PFS and OS of the patients; (B) PFS and OS according to international prognostic index (IPI); (C) PFS and OS according to prognostic index of natural-killer lymphoma-Epstein-Barr Virus (PINK-E); (D) PFS and OS according to prognostic index of natural-killer lymphoma (PINK).